• Explore /
  • Poster
  • / Absence of interaction of cabazitaxel on the pharmacokinetics of midazolam: Results of a drug–drug interaction study in patients with advanced solid tumors.

Absence of interaction of cabazitaxel on the pharmacokinetics of midazolam: Results of a drug–drug interaction study in patients with advanced solid tumors.

Abstract Poster

Authors

null

Olivier Rixe

Georgia Health Sciences University, Augusta, GA

Olivier Rixe , John Sarantopoulos , Chung-Tsen Hsueh , A. Craig Lockhart , Sharona Ross , Sanjiv S. Agarwala , Wendy Zhang , Jian Y. Yin , Claudine Wack , Florent Mazuir , Jayne S. Gurtler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT01140607

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 126)

DOI

10.1200/jco.2013.31.6_suppl.126

Abstract #

126

Poster Bd #

H9

Abstract Disclosures

Similar Posters

First Author: Lee Steven Schwartzberg

First Author: Serena Marchetti

First Author: Johanna C. Bendell

Poster

2019 Gastrointestinal Cancers Symposium

Dose escalation and expansion cohort study for DS-8895a in patients with advanced solid tumors.

Dose escalation and expansion cohort study for DS-8895a in patients with advanced solid tumors.

First Author: Taroh Satoh